AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
CEL-SCI Corporation Extends Agreement With U.S. Navy For Vaccine Collaboration.(malaria vaccine)
2001 OCT 10 - (NewsRx.com & NewsRx.net) --
CEL-SCI Corporation announced that its Cooperative Research and Development Agreement (CRADA) with the Naval Medical Research Center (NMRC) of the U.S. Navy to jointly develop a malaria vaccine utilizing CEL-SCI's L.E.A.P.S. (Ligand Epitope Antigen Presentation System) technology has been extended for a third time.
In October 2000, the Naval Medical Research Center and CEL-SCI announced that an experimental peptide, based on CEL-SCI's L.E.A.P.S. technology, induced protective immune responses against challenge from malaria-causing organisms. The data were presented by scientists from the NMRC and CEL-SCI at the 49th Annual Meeting of the American Society of Tropical Medicine and Hygiene.
Malaria affects about 300-500 million people per year and is responsible for about 2.7 million deaths annually. It is a parasitic disease that is transmitted by mosquitoes. As with tuberculosis, the number one killer ahead of malaria, the emergence of drug resistant strains is a major problem, as is the emergence of insecticide resistant strains of mosquitoes. While at present, the numbers of deaths and cases of malaria are not a problem in the continental USA, there are more and more cases of Americans bringing the disease home from overseas travels.
L.E.A.P.S. is a novel T-cell modulation platform ...
- Epimmune Expands Collaboration With the Naval Medical Research Center (Malaria...
- Press release article from: PR Newswire September 28, 2000 700+ words
...collaboration with the Naval Medical Research Center (NMRC) Malaria Program...that Epimmune and the Naval Medical Research Center can use to determine...Malaria Program, Naval Medical Research Center. Epimmune is developing...
- Studies from Naval Medical Research Center provide new data on malaria...
- Newspaper article from: AIDS Vaccine Week August 31, 2009 700+ words
...wrote K.J. Limbach and colleagues, Naval Medical Research Center. The researchers concluded: "Significant...Limbach, US Military Malaria Vaccine Program, Naval Medical Research Center, 503 Robert Grant Avenue, Silver Spring...
- GenVec, U.S. Naval Medical Research Center and Path's Malaria Vaccine...
- Press release article from: PR Newswire March 31, 2004 700+ words
...Vaccine Initiative (MVI) and the U.S. Naval Medical Research Center (NMRC) today announced a dynamic partnership...please visit http://www.path.org/. The Naval Medical Research Center (NMRC) conducts basic and applied research...
- Recent findings from Naval Medical Research Center highlight research in blood...
- Newspaper article from: Blood Weekly November 20, 2008 700+ words
...hemostasis," wrote F. Arnaud and colleagues, Naval Medical Research Center. The researchers concluded: "However, there...contacting F. Arnaud, Combat Casualty Care, Naval Medical Research Center, 503 Robert Grant Avenue, Silver Spring...
- Findings in coagulation reported from Naval Medical Research Center.
- Newspaper article from: Blood Weekly October 15, 2009 700+ words
...wrote J.S. Hawksworth and colleagues, Naval Medical Research Center (see also Coagulation). The researchers...Casualty Care, Regenerative Medicine Department, Naval Medical Research Center, Silver Spring, MD 20910 USA.. Publisher...
- Research on stem cell research reported by scientists at Naval Medical Research...
- Newspaper article from: Blood Weekly November 13, 2008 700+ words
...mice," wrote T.A. Davis and colleagues, Naval Medical Research Center (see also Stem Cell Research). The researchers...Directorate, Regenerative Medicine Department, Naval Medical Research Center, Silver Spring, MD 20910 USA.. Publisher...
- U.S. Naval Medical Research Center Proposed 'RESUS' Clinical Trial in Trauma...
- News wire article from: PR Newswire May 18, 2009 700+ words
...FirstCall/ -- Biopure Corporation announced today that the Food and Drug Administration has advised the U.S. Naval Medical Research Center (NMRC) by letter that it may not initiate a clinical trial of Biopure's oxygen therapeutic Hemopure...
- U.S. Naval Medical Research Center Resubmits IND Application for Proposed 'Op...
- Press release article from: PR Newswire December 2, 2008 700+ words
...CAMBRIDGE, Mass., Dec. 2 /PRNewswire-FirstCall/ -- Biopure Corporation announced today that the U.S. Naval Medical Research Center (NMRC) has submitted to the Food and Drug Administration (FDA) a revised investigational new drug (IND...